U.S. market Closed. Opens in 7 hours 45 minutes

XFOR | X4 Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/AN/A3.00MN/A3.50MN/AN/AN/A
Cost of Revenue2.00M1.99M1.89MN/A672.00K103.00K195.00K300.00K400.00K
Gross Profit-2.00M-1.99M-1.89M3.00M-672.00K3.40M-195.00K-300.00K-400.00K
Operating Expenses107.52M88.08M75.35M62.87M47.80M46.21M32.27M21.96M12.67M
Selling, General & Admin35.51M27.02M24.70M20.94M17.64M18.41M8.01M6.51M2.12M
Research & Development70.02M61.06M50.65M41.93M30.16M30.98M28.13M17.83M12.71M
Other Operating ExpensesN/A-6.27M-3.57M-2.11M-1.10M-85.00K-16.00K104.00K-77.00K
Operating Income-107.52M-87.57M-85.11M-59.87M-51.70M-45.88M-36.13M-24.35M-14.82M
Other Expenses / Income6.43M-6.27M-3.57M-2.11M-1.10M2.86M2.26M6.48M1.61M
Before Tax Income-101.09M-93.84M-88.68M-61.98M-52.81M-43.02M-33.88M-22.98M-13.22M
Income Tax Expenses78.00K28.00K17.00K148.00K3.80M3.90M1.87M2.62M395.00K
Net Income-101.17M-93.87M-88.70M-62.13M-56.60M-43.02M-33.88M-22.98M-13.22M
Interest Expenses5.78M3.99M3.64M2.69M2.15M1.04M2.08M2.52M472.00K
Basic Shares Outstanding177.81M63.53M25.75M20.08M11.53M459.00K343.64K928.01K928.01K
Diluted Shares Outstanding177.81M63.53M25.75M20.08M11.53M459.00K343.64K928.01K928.01K
EBITDA-107.10M-87.57M-85.11M-58.06M-51.70M-45.88M-31.60M-20.16M-12.35M
EBITDA Margin0.00%0.00%0.00%-1,935.50%0.00%-1,311.00%0.00%0.00%0.00%
EBIT-95.31M-89.85M-85.04M-59.30M-50.66M-38.08M-29.93M-17.84M-12.35M
EBIT Margin0.00%0.00%0.00%-1,976.50%0.00%-1,087.97%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙